Erratum: Differences in the volume of pharmaceutical advertisements between print general medical journals (PLoS ONE (2014) 9:1 (e84790) DOI:10.1371/journal.pone.0084790);Differences in the volume of pharmaceutical advertisements between print general medical journals

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Gettings, Jennifer ^a   O'Neill, Braden ^b,c   Chokshi, Dave A ^d   Colbert, James A ^e,f   Gill, Peter ^b,g   Lebovic, Gerald ^h,i   Lexchin, Joel ^j,k,l   Persaud, Navindra ^a,l,m  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CALGARY   (Canada)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f NEWTON WELLESLEY HOSPITAL   (United States)

^g UNIVERSITY OF ALBERTA   (Canada)

^h ST MICHAEL'S HOSPITAL   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j YORK UNIVERSITY   (Canada)

^k UNIVERSITY HEALTH NETWORK   (Canada)

^l UNIVERSITY OF TORONTO   (Canada)

^m ST MICHAEL'S HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; COST CONTROL; DRUG MARKETING; MEDICAL INFORMATION; MEDICAL LITERATURE; UNITED KINGDOM; UNITED STATES;

ADVERTISING AS TOPIC; DRUG INDUSTRY; JOURNALISM, MEDICAL; PERIODICALS AS TOPIC; PRINTING;

EID: 84896517964     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091628     Document Type: Erratum

References (25)

1. Canadian Medical Association Journal 2013 Media Kit. Available at: http://www.cmaj.ca/site/pdfs/cmaj-2013.pdf. Accessed 2 August, 2013.
2. British Medical Journal Advertising Opportunities 2013. Available at:http://group.bmj.com/group/advertising/Print%202013%20Media%20Pack.pdf. Accessed 2 August, 2013.
3. The Journal of the American Medical Association 2013 Print Edition Rate Card. Available at:http://files.jamanetwork.com/jn/jama-rates-2013.pdf. Accessed 2 August, 2013.
4. New England Journal of Medicine 2013 U.S. rates, specifications & general information. Available at: http://www.nejmadsales.org/wp-content/ uploads/NEJM-US-RateCard-2013.pdf. Accessed 2 August 2013.
5. Canadian Family Physician 2013 Rate Card. Available at: http://www.cfp.ca/site/misc/Advertising/RateCard2013.pdf. Accessed 2 August 2013.
6. Why advertise in the Lancet? Available at: http://download.thelancet.com/ flatcontentassets/about/display-pack-july-2008.pdf. Accessed 18 August 2013.
7. Medical Media Study 2012 Technical Appendix. Available at: http://www.pmb.ca/public/e/mms2012/MMS2012-tech-appx.pdf. Accessed 17 September 2013.
8. Wilkes MS, Doblin BH, Shapiro MF (1992) Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med116:912-919. (Pubitemid 23034784)
9. Othman N, Vitry AI, Roughead EE (2012) Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States. BMC Public Health10:294.
10. Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, et al. (2010) Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med 7:e1000352.
11. Cooper RJ, Schriger DL (2005) The availability of references and the sponsorship of original research cited in pharmaceutical advertisements. CMAJ172:487-491.
12. Lexchin J, Holbrook A (1994) Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. CMAJ 151:47-54. (Pubitemid 24246394)
13. Lankinen KS, Levola T, Marttinen K, Puumalainen I, Helin-Salmivaara A (2004) Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals. Pharmacoepidem Dr S 13:789-795. (Pubitemid 39496901)
14. Becker A, Dorter F, Eckhardt K, Viniol A, Baum E, et al. (2011) The association between a journal's source of revenue and the drug recommendations made in the articles it publishes. CMAJ 183:544-548.
15. Fletcher RH (2003) Adverts in medical journals: caveat lector. Lancet361:10-11.
16. Smith R(2007) Should medical journals carry drug advertising? Yes. BMJ335:74.
17. Bank of Canada Financial Markets Department Year Average of Exchange Rates. Available at: http://www.bankofcanada.ca/stats/assets/pdf/nraa-2012.pdf. Accessed 18 August 2013.
18. Board of Governors of the Federal Reserve System Foreign Exchange Rates. Available at: http://www.federalreserve.gov/releases/g5a/current/. Accessed 18 August 2013.
19. Gaddis GM, Olson JE, Wright DW(2009) Academic Emergency Medicine can print pharmaceutical advertising while not compromising its mission or its integrity. AcadEmerg Med 16:978-981.
20. Dehaas D (2010) Should medical journals carry pharmaceutical advertising? YES. Can Fam Physician 56:978,980, 982-984; discussion e358, e360.
21. Villanueva P, Peiro S, Librero J, Pereiró I (2003) Accuracy of pharmaceutical advertisements in medical journals. Lancet 361:27-32. (Pubitemid 36050958)
22. Handel AE, Patel SV, Pakpoor J, Ebers GC, Goldacre B, et al. (2012) High reprint orders in medical journals and pharmaceutical industry funding: case-control study. BMJ 344:e4212.
23. Petch J, Dhalla IA, Henry DA, Schultz SE, Glazier RH, et al. (2012) Public Payments to Physicians in Ontario Adjusted for Overhead Costs. Health Policy 8:30-36.
24. Lexchin J (2009) CJEM and pharmaceutical advertisements: it's time for an end. CJEM 11:375-384.
25. Drazen JM, de Leeuw PW, Laine C, Mulrow C, Deangelis CD, et al. (2012) Toward more uniform conflict disclosures: the updated ICMJE conflict of interest reporting form. N Engl J Med 363:188-189.